0001209191-12-028597.txt : 20120516
0001209191-12-028597.hdr.sgml : 20120516
20120516163612
ACCESSION NUMBER: 0001209191-12-028597
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120515
FILED AS OF DATE: 20120516
DATE AS OF CHANGE: 20120516
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139-4242
BUSINESS PHONE: 6165776000
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MUELLER PETER
CENTRAL INDEX KEY: 0001256126
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 12849238
4
1
doc4.xml
FORM 4 SUBMISSION
X0305
4
2012-05-15
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001256126
MUELLER PETER
C/O VERTEX PHARMACEUTICALS INCORPORATED
130 WAVERLY ST
CAMBRIDGE
MA
02139
0
1
0
0
EVP, Global R&D, CSO
Common Stock
2012-05-15
4
M
0
6500
16.32
A
138816
D
Common Stock
2012-05-15
4
S
0
2100
63.84
D
136716
D
Common Stock
2012-05-15
4
S
0
3700
64.30
D
133016
D
Common Stock
2012-05-15
4
S
0
700
65.50
D
132316
D
Common Stock
4367
I
401(k)
Common Stock
15920
I
Common Stock held in trust.
Stock Option
16.32
2012-05-15
4
M
0
6500
0.00
D
2003-10-15
2013-07-14
Common Stock
6500
42300
D
Transaction made pursuant to Dr. Mueller's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $63.84 (range $63.63 to $63.99).
Dr. Mueller undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $64.30 (range $64.01 to $64.85).
Open market sales reported on this line occurred at a weighted average price of $65.50 (range $65.00 to $65.93).
Common stock held in grantor retained annuity trusts.
David T. Howton, Attorney-In-Fact
2012-05-16